MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma

MicroRNA200a enhances antitumor effects in combination with doxorubicin in hepatocellular carcinoma

Hepatocellular carcinoma (HCC) is often treated with doxorubicin. MicroRNAs have been shown to have important regulatory roles in cancer and serve as a target in chemoresistance. In this study, we investigated the effects of specific microRNA-200a (miR-200a) on HCC tumor cell growth and effect of do...

Full beskrivning

Bibliografiska uppgifter
Huvudupphovsmän: Xiao Cui, Dachen Zhou, Qiang Du, Peiqi Wan, Kun Dong, Hui Hou, David A. Geller
Materialtyp: Artikel
Språk:English
Publicerad: Elsevier 2020-10-01
Serie:Translational Oncology
Länkar:http://www.sciencedirect.com/science/article/pii/S1936523320303004

Liknande verk

Liknande verk